About BioCircuit
BioCircuit is a company based in Atlanta (United States) founded in 2016. BioCircuit has raised $13.65 million across 7 funding rounds from investors including NIH, HHS and Masters Capital Management. BioCircuit offers products and services including Nerve Tape. BioCircuit operates in a competitive market with competitors including Avation, Epineuron, Tulavi Nerve Therapeutics, Micro Leads and Renerva, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocircuit Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.65 M (USD)
in 7 rounds
-
Latest Funding Round
$1.89 M (USD), Grant
Sep 22, 2023
-
Investors
NIH
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCircuit
BioCircuit offers a comprehensive portfolio of products and services, including Nerve Tape.
Sutureless tool for faster and stronger nerve repairs in surgeries.
People of BioCircuit
Unlock access to complete
Unlock access to complete
Funding Insights of BioCircuit
BioCircuit has successfully raised a total of $13.65M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.89 million completed in September 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioCircuit
BioCircuit has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Masters Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed & early stage sector-agnostic venture capital firm funding companies in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for BioCircuit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioCircuit
Investment portfolio details for BioCircuit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioCircuit
Detailed financials for BioCircuit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocircuit Comparisons
Peer comparison for BioCircuit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioCircuit
BioCircuit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avation, Epineuron, Tulavi Nerve Therapeutics, Micro Leads and Renerva, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable tibial nerve stimulation device treats overactive bladder symptoms.
|
|
| Locked | Locked | Locked |
Medical devices for peripheral nerve injury treatment are provided.
|
|
| Locked | Locked | Locked |
Therapeutic devices for neurally mediated diseases are developed.
|
|
| Locked | Locked | Locked |
Micro-cuff electrodes and wireless pulse generators for neuromodulation are developed.
|
|
| Locked | Locked | Locked |
Implants for peripheral nerve repair are developed for injury treatment.
|
Detailed competitors of BioCircuit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocircuit
Complete news archive for BioCircuit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioCircuit
BioCircuit was founded in 2016 and raised its 1st funding round 3 years after it was founded.
BioCircuit is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Michelle Jarrard is the current CEO of BioCircuit.
BioCircuit is a funded company, having raised a total of $13.65M across 7 funding rounds to date.
BioCircuit was founded in 2016 in Atlanta, United States, within the medical devices sector. Non-invasive electrophysiology devices are produced by the company to assess peripheral nerve activity. A multielectrode array-based technology, supported by proprietary algorithms, is utilized for testing nerve function. Operations focus on advancing diagnostic tools for neurological monitoring, with leadership provided by CEO Michelle Jarrard.
BioCircuit's top competitors include Avation, Tulavi Nerve Therapeutics and Epineuron.
BioCircuit offers Nerve Tape.
BioCircuit has 5 investors. Key investors include NIH, HHS, Masters Capital Management, GRA Venture Fund, and Alsora Capital.